Group 1 - Watsons is planning a dual listing in Hong Kong and London, aiming to raise approximately $2 billion, with a valuation expected to exceed $30 billion [3][5] - Watsons has over 16,900 stores and 175 million members globally, but its financial performance is declining, particularly in China, where operating profit is projected to drop by 130% in 2024 [7] - The company is implementing various self-rescue measures, including the "O+O" cloud store model and management restructuring, to reverse its declining trend [7] Group 2 - Beijing Plant Doctor is advancing its IPO process, aiming to raise 998 million yuan, with a focus on high-altitude plant skincare products [8][10] - If successful, Plant Doctor will become the first single-brand cosmetics company listed on A-shares, with 4,328 offline stores and a revenue of 2.156 billion yuan in 2024 [8][10] - The funds from the IPO will be used for marketing, brand building, and upgrading production facilities [10] Group 3 - Sanofi plans to spin off its hair health and consumer medical business, Mandi International, and has submitted an application for a mainboard listing in Hong Kong [12] - Mandi is the largest minoxidil brand in China, holding a 57% market share in the hair loss medication market and a 71% share in the minoxidil segment [12] - The IPO funds will be allocated to enhance R&D capabilities and digital operations [12] Group 4 - Shandong Anhua Bio-Pharmaceutical has returned to the New Third Board after a four-year absence, focusing on hyaluronic acid production [13][15] - The company's revenue increased from 98.09 million yuan to 114 million yuan, but net profit fell significantly from 12.49 million yuan to 5.12 million yuan [13] - Anhua is shifting its strategic focus to the medical device industry to seek growth [15] Group 5 - Green Biological Technology has submitted its third IPO application to the Shenzhen Stock Exchange, aiming to raise 690 million yuan [16][18] - The company specializes in the research and production of fragrance products, with a revenue of 961 million yuan and a net profit of 150 million yuan in 2024 [18] - If successful, the IPO will help consolidate its position in the global fragrance supply chain [18] Group 6 - Hourglass founder Carisa Janes has launched a new brand, Outside In, with plans for a physical store in New York by spring 2026 [20] - Outside In focuses on a slow-paced strategy that emphasizes product quality over rapid expansion, offering a mix of skincare and makeup products [20] Group 7 - The sixth China Cosmetics Annual Conference concluded successfully, attracting over 3,000 attendees and 18,000 online viewers [21][23] - Industry leaders discussed the shift from quantity-driven growth to value-driven quality improvements in the cosmetics sector [23]

Investment Rating - The report does not explicitly state the investment rating for Yatsen Holding (YSG US) Core Insights - Yatsen Holding's revenue for Q2 2025 reached 1.09 billion yuan, a year-on-year increase of 36.8%, driven by strong performance in skincare brands and stable growth in color cosmetics [2][10] - The gross profit for Q2 2025 was 850 million yuan, reflecting a 39.5% year-on-year increase, with a gross profit margin of 78.3%, up 1.6 percentage points from the previous year [2][10] - The company expects Q3 2025 net revenue to be between 790 million yuan and 880 million yuan, representing a year-on-year growth of approximately 15% to 30% [2][10] Revenue Performance - Skincare brands contributed significantly, with net revenue increasing by 78.7% year-on-year to 580 million yuan, accounting for 53.5% of total revenue [2][10] - The three core skincare brands saw revenue growth of 88.1%, while color cosmetics brands experienced an 8.8% increase, with the Perfect Diary brand returning to growth [2][10] Expense Management - Total operating expenses for Q2 2025 were 910 million yuan, a year-on-year increase of 21.7%, but the operating expense ratio decreased by 10.3 percentage points to 83.4% [3][11] - Fulfillment expenses were 63.29 million yuan, with a fulfillment expense ratio of 5.8%, down 0.6 percentage points year-on-year [3][11] - Sales and marketing expenses were 720 million yuan, with a sales and marketing expense ratio of 66.5%, down 2.1 percentage points year-on-year [3][11] Profitability - Operating loss for Q2 2025 narrowed to 55.48 million yuan, down from 135 million yuan in the same period last year, with an operating loss margin of 5.1% [4][12] - Non-GAAP net profit turned positive at 11.5 million yuan, compared to a non-GAAP net loss of 74.89 million yuan in the previous quarter [4][12] Strategic Outlook - The company is confident in maintaining a balance between growth and profitability, particularly in high-end skincare brands which typically yield higher gross margins [5][13] - Yatsen has been actively investing in R&D, establishing a world-class R&D center in Shanghai to enhance its competitive advantage [5][13] Brand Development - Continuous investment in product R&D and brand building has led to strong performance, with flagship products like the VC serum and innovative offerings in color cosmetics [6][14] - The company is expanding its offline presence with experience stores in major cities to enhance brand influence and consumer interaction [6][14]